Neoadjuvant chemotherapy in ER-positive Early Breast Cancer: predictive factors of response and outcome

被引：0
|
作者：
Kouadri, N. [1 ]
Boudersa, A. [1 ]
Bouguetaya, A. [1 ]
Djedi, H. [1 ]
机构：
[1] UH Annaba, Annaba, Algeria
来源：
BREAST | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P129
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [1] PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
    Ohara, Ako Matsushita
    Naoi, Yasuto
    Shimazu, Kenzo
    Kagara, Naofumi
    Shimoda, Masafumi
    Tanei, Tomonori
    Miyake, Tomohiro
    Kim, Seung Jin
    Noguchi, Shinzaburo
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (03) : 533 - 543
  • [2] PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
    Ako Matsushita Ohara
    Yasuto Naoi
    Kenzo Shimazu
    Naofumi Kagara
    Masafumi Shimoda
    Tomonori Tanei
    Tomohiro Miyake
    Seung Jin Kim
    Shinzaburo Noguchi
    [J]. Breast Cancer Research and Treatment, 2019, 173 : 533 - 543
  • [3] CHEMORESISTANCE TO NEOADJUVANT CHEMOTHERAPY IN YOUNG PATIENTS WITH ER-POSITIVE BREAST CANCER
    Moon, B.
    Seoh, J.
    Woo, J.
    Lim, W.
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [4] The neoadjuvant endocrinetherapy vs chemotherapy in postmenopausal woment with ER-positive breast cancer
    Semiglazov, V. F.
    Semiglazov, V. V.
    Ivanov, V. G.
    Zhiltzova, E. R.
    Kletsel, A. E.
    Dashyan, G. A.
    Bozhok, A. A.
    Paltuev, R. M.
    Berstein, L. M.
    Krivorotko, R. V.
    [J]. BREAST, 2007, 16 : S50 - S50
  • [5] Predictive Factors of Response to Neoadjuvant Chemotherapy in Hormone Receptor Positive Breast Cancer
    Lai, L.
    Ottesen, R.
    Niland, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S62 - S63
  • [6] Neoadjuvant endocrine therapy vs chemotherapy for postmenopausal ER-positive breast cancer patients
    Semiglazov, VF
    Ivanov, VG
    Semiglazov, VV
    Ziltsova, EK
    Keltzel, AA
    Melnikova, OA
    Topuzov, EE
    Paltuev, RM
    Bozhok, AA
    Dashian, GA
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S106 - S107
  • [7] Low Estrogen Receptor ( ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy Is Response Similar to Typical ER-Positive or ER-Negative Disease?
    Landmann, Alessandra
    Farrugia, Daniel J.
    Zhu, Li
    Diego, Emilia J.
    Johnson, Ronald R.
    Soran, Atilla
    Dabbs, David J.
    Clark, Beth Z.
    Puhalla, Shannon L.
    Jankowitz, Rachel C.
    Brufsky, Adam M.
    Ahrendt, Gretchen M.
    McAuliffe, Priscilla F.
    Bhargava, Rohit
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 (01) : 34 - 42
  • [8] Endo Predict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer
    Bertucci, Francois
    Finetti, Pascal
    Viens, Patrice
    Birnbaum, Daniel
    [J]. CANCER LETTERS, 2014, 355 (01) : 70 - 75
  • [9] Neoadjuvant Chemotherapy for Luminal A Breast Cancer: Factors Predictive of Histopathologic Response and Oncologic Outcome
    Collins, P.
    Brennan, M.
    Elliott, J.
    Abd Elwahab, S.
    Barry, K.
    Sweeney, K.
    Malone, C.
    Lowery, A.
    McLaughlin, R.
    Kerin, M. J.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S185 - S185
  • [10] Neoadjuvant Chemotherapy for Luminal a Breast Cancer: Factors Predictive of Histopathologic Response and Oncologic Outcome
    Collins, P.
    Brennan, M.
    Elliott, J.
    Elwahab, S. A.
    Barry, K.
    Sweeney, K.
    Malone, C.
    Lowery, A.
    McLaughlin, R.
    Kerin, M.
    [J]. BRITISH JOURNAL OF SURGERY, 2020, 107 : 23 - 23
12345